Company News
Sun Pharma Seeks Shareholder Approvals for ESOP and Acquisition
Sun Pharma proposes new ESOP 2026 plan for up to 12 million options using secondary market shares without dilution.
Company seeks enhanced borrowing limit of ₹700 billion and investment limit of ₹800
